Se­lec­ta turns to syn­bio play­er for $1.1B cap­sid deal; BioN­Tech signs $790M im­munother­a­py deal

Se­lec­ta Bio­sciences has turned to one of the re­cent dar­lings in the syn­bio biz for its lat­est col­lab­o­ra­tion.

Gink­go Bioworks has signed on to a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.